Age: 75.0
Sex: F
Vaccine: COVID19, FLUA3
Symptoms: Blood glucose normal, Blood urea, C-reactive protein increased, Cartilage injury, Fatigue
Clinical narrative: pain/Achy; Tiredness; mild flu-like symptoms; soreness in arm shot location; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (mild flu-like symptoms), VACCINATION SITE PAIN (soreness in arm shot location), PAIN (pain/Achy) and FATIGUE (Tiredness) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A, 029A21A, 045J21A and 002M21A) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE INACT SAG 3V (FLUAD) for an unknown indication.    The patient's past medical history included Knee surgery NOS in 1991. Previously administered products included for Product used for unknown indication: Spikevax. Past adverse reactions to the above products included No adverse event with Spikevax. Concurrent medical conditions included Drug allergy (Aspirin allergy), Penicillin allergy, Drug allergy (Codeine allergy), Drug allergy (Tramadol allergy), Drug allergy, Drug allergy (Ibuprofen allergy), Latex allergy (Latex allergy), Food allergy (Food coloring allergy), Blood pressure high since 30-Jan-2015, Glaucoma since 28-Mar-2018, Borderline diabetes (Improvement in condition) since 28-Mar-2018 and Osteoporosis since 28-Mar-2015. Concomitant products included LOSARTAN from 30-Jan-2015 to an unknown date and METOPROLOL SUCCINATE from 20-Jun-2022 to an unknown date for Blood pressure management, LATANOPROST from 28-Mar-2018 to an unknown date for Glaucoma, HYDROCODONE for an unknown indication.   On 04-Feb-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2022, the patient received first dose of INFLUENZA VACCINE INACT SAG 3V (FLUAD) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (mild flu-like symptoms), VACCINATION SITE PAIN (soreness in arm shot location), PAIN (pain/Achy) and FATIGUE (Tiredness). At the time of the report, INFLUENZA LIKE ILLNESS (mild flu-like symptoms) and VACCINATION SITE PAIN (soreness in arm shot location) had resolved and PAIN (pain/Achy) and FATIGUE (Tiredness) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Nov-2022, Magnetic resonance imaging: Status post anterior cruciate ligament reconstruction by means of a patellar tendon autograft. The graft is isometric and impingement free. The menisci are normal. Partially ruptured popliteal cyst. Mild grade muscle strain of the lateral head of the gastrocnemius. Patellofemoral articular cartilage damage. . On 16-Dec-2022, Blood glucose (65-99 mg/dl): 111 mg/dl. On 16-Dec-2022, C-reactive protein: more than 10.0 mg/L (Ref. range : less than 1.0).     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was reported.  On 16-Dec-2022, Blood urea test was performed (result : not reported).  Reported stated that previous vaccine shots and booster gave mild flu-like symptoms and soreness in arm shot location which all resolved in 2 days.  It was unknown if the patient experienced any additional symptoms/events.   This case was linked to MOD-2022-687681 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2023: Follow up received contains no new information. On 24-Jan-2023: Follow up document received contains no new information. On 26-Jan-2023: Significant follow up received contains concomitant drug added, events added.